Serum galectin-3 level in systemic sclerosis.

Suleyman Serdar Koca1, Fatma Akbas, Metin Ozgen

  • 1Department of Rheumatology, Faculty of Medicine, Firat University, 23119, Elazig, Turkey, kocassk@yahoo.com.

Clinical Rheumatology
|August 6, 2013
PubMed
Summary

Serum galectin-3 levels are elevated in patients with Systemic Sclerosis (SSc) and Systemic Lupus Erythematosus (SLE). Higher galectin-3 indicates active disease, suggesting its potential as a biomarker for SSc activity.

Related Concept Videos